安济盛生物医药技术（广州）有限公司

Angitia Biopharmaceuticals (Guangzhou) Co., Ltd., strategically positioned in Guangzhou Science City, is a pioneering pharmaceutical tech company dedicated to the innovation and development of therapeutic solutions for skeletal, muscular, and joint ailments. Our operations extend to California, USA. Our founding team and core personnel bring extensive experience in drug development and management from leading multinational corporations both abroad and within China.

Equipped with a specialized research team boasting expertise in new drug target identification, we delve deeply into the pathophysiology of musculoskeletal disorders. Leveraging advancements in genetics and molecular biology, we uncover novel mechanisms, signaling pathways, and their interactions, facilitating the discovery of new drug targets. This is complemented by our commitment to computer-aided drug design, enabling the creation of innovative biologics and small molecules.

Our product development strategy encompasses both internal research efforts and strategic partnerships with academic institutions and global research entities, all aimed at serving patients in need. Our culture fosters an open, inclusive environment that embodies humanistic values.

We warmly invite professionals characterized by competence, positivity, ambition, and a strong collaborative spirit to join our dynamic team.

Our Vision: To pioneer transformative therapeutics that significantly alleviate the burden of severe musculoskeletal diseases.